Michael Shetzline
Senior Vice President, Chief Medical Officer, and Head of Research and Drug DevelopmentatIronwood Pharmaceuticals· In proxies 2021–2024
Pay in FY2024Ironwood Pharmaceuticals stock -61.3% the same year
Michael Shetzline was paid $2.7M in FY2024 (Dec). Ironwood Pharmaceuticals stock fell 61.3% that year.
Pay$100 in the stock at the end of FY20 → $42
Experience
- Ironwood PharmaceuticalsPublic company · 5 yr
- Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development2021 – Present · 5 yrStock in role -69%
;}%20.st1{fill-rule:evenodd;clip-rule:evenodd;fill:%23666868;}%20.st2{fill:%2399C13C;}%20.st3{fill:%237A9E3F;}%20.st4{fill:%23BED63A;}%20.st5{fill:%23666868;}%3c/style%3e%3cg%3e%3cdefs%3e%3crect%20id='SVGID_1_'%20x='4.7'%20y='3.6'%20width='241.2'%20height='53'/%3e%3c/defs%3e%3cclipPath%20id='SVGID_00000066476568263475870400000002741637092662773422_'%3e%3cuse%20xlink:href='%23SVGID_1_'%20style='overflow:visible;'/%3e%3c/clipPath%3e%3cg%20id='Group_6'%20transform='translate(0%200)'%20style='clip-path:url(%23SVGID_00000066476568263475870400000002741637092662773422_);'%3e%3cpath%20id='Path_1'%20class='st1'%20d='M85.4,32.4c-0.8-0.9-1.9-1.5-3.1-1.6c-1.8,0-3.2,1.1-6,4.6v-4h-4.2v23.8h4.2V41%20c2.2-4,4-6.1,5.4-6.1c0.4,0,0.8,0.2,1.6,0.9l0.1,0.1L85.4,32.4L85.4,32.4z%20M95.7,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C107.4,36.3,102.2,30.7,95.7,30.7%20M95.7,52c-4,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S99.7,52,95.7,52%20M63.6,55.1h4.5V20.6h-4.5V55.1z%20M231.7,17v15.2c-1.6-1.1-3.5-1.6-5.5-1.5%20c-7,0-12.1,5.5-12.1,13.2c0,7,4.1,11.9,9.9,11.9c2.9,0,5.7-1.3,7.6-3.4v2.7h4.2V17H231.7z%20M231.7,47.8c-0.7,0.9-1.5,1.8-2.5,2.5%20c-1.3,1-2.9,1.5-4.5,1.6c-3.6,0-6.1-3.4-6.1-8c0-5.5,3.2-9.1,8-9.1c2.4,0,3.9,0.7,4.6,1.9c0.4,0.8,0.5,1.3,0.5,3L231.7,47.8z%20M200.4,30.7c-6.5,0-11.8,5.6-11.8,12.5c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C212.1,36.3,206.8,30.7,200.4,30.7%20M200.4,52c-4,0-7.2-3.9-7.2-8.8s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S204.4,52,200.4,52%20M175.3,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C187,36.3,181.7,30.7,175.3,30.7%20M175.3,52c-4.1,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S179.3,52,175.3,52%20M123.1,30.7c-2.3,0-4.6,0.9-6.4,2.4c-1.1,0.9-2.1,1.9-3,2.9v-4.7h-4.2%20v23.8h4.2V40.7c4-4.5,6.5-6.2,8.9-6.2c0.9-0.1,1.8,0.4,2.3,1.2c0.3,0.9,0.4,1.8,0.3,2.7v16.8h4.2V37.4%20C129.5,32.9,127.4,30.7,123.1,30.7%20M160.5,31.3c0,0-5.6,18-5.8,18.5c-0.8-2.4-6.1-18.4-6.1-18.4l0-0.1h-4.4c0,0,1.6,4.1,1.6,4.2%20c0,0.1-5,13.8-5.2,14.3c-0.7-2.3-5.6-18.5-5.6-18.5l0-0.1h-4.6l7.9,24.4h3.5l5.6-14.8c0,0,0.1-0.4,0.2-0.8l0.2,0.8%20c0,0,5.3,14.8,5.3,14.8h3.4l8.2-24.4L160.5,31.3z'/%3e%3cpath%20id='Path_2'%20class='st2'%20d='M24.2,55.1c0.2-6.8-1.5-13.5-4.9-19.4C15.8,29.7,10.8,24.6,4.8,21c-0.2,6.8,1.5,13.5,4.9,19.4%20C13.1,46.5,18.2,51.5,24.2,55.1'/%3e%3cpath%20id='Path_3'%20class='st3'%20d='M30.9,56.6c2.2-9.5,1.8-19.4-1.3-28.6c-3.2-9.4-8.8-17.8-16.3-24.4c-2.2,9.5-1.8,19.4,1.3,28.6%20C17.8,41.6,23.4,50,30.9,56.6'/%3e%3cpath%20id='Path_4'%20class='st4'%20d='M38.7,55.1c5.8-5.1,10.1-11.7,12.5-19c2.3-7.2,2.6-14.9,0.8-22.2c-5.8,5.1-10.1,11.7-12.5,19%20C37.2,40.1,36.9,47.8,38.7,55.1'/%3e%3cpath%20id='Path_5'%20class='st5'%20d='M242.6,23.6c-1.9,0-3.4-1.5-3.4-3.4c0-1.9,1.5-3.4,3.4-3.4c1.9,0,3.4,1.5,3.4,3.4%20C246,22,244.5,23.6,242.6,23.6%20M242.6,17.3c-1.6,0-2.9,1.3-2.9,2.9s1.3,2.9,2.9,2.9c1.6,0,2.9-1.3,2.9-2.9c0,0,0,0,0,0%20C245.5,18.6,244.2,17.3,242.6,17.3%20M243.5,22.1l-1.2-1.6h-0.4v1.6h-0.7v-3.9h1.4c1,0,1.5,0.3,1.5,1.1c0,0.6-0.4,1.1-1,1.1%20c0,0,0,0,0,0l1.3,1.7L243.5,22.1z%20M243.1,18.8c-0.2-0.1-0.4-0.1-0.6-0.1h-0.6V20h0.6c0.6,0,0.9-0.2,0.9-0.7%20C243.4,19.1,243.3,18.9,243.1,18.8'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?